-
Notifications
You must be signed in to change notification settings - Fork 1
revise dfda-cost-benefit-analysis #48
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Conversation
…lect the rebranding of "dFDA Platform" to "Decentralized FDA" and enhance clarity in QALY projections. Changes include improved hyperlink references and detailed explanations of QALY gains, ensuring accurate representation of the platform's impact on public health interventions.
…tions and operational cost scenarios. Key changes include a detailed breakdown of annual QALYs gained across conservative, base, and optimistic scenarios, along with refined operational cost estimates, enhancing the clarity and comprehensiveness of the economic model analysis.
Reviewer's GuideThis PR refactors the cost–benefit analysis by moving the detailed QALY calculation into a dedicated appendix, standardizing anchor references, updating platform cost and QALY scenario figures, enriching the context with new source citations, and renaming the chart script label for clarity. File-Level Changes
Tips and commandsInteracting with Sourcery
Customizing Your ExperienceAccess your dashboard to:
Getting Help
|
There was a problem hiding this comment.
Choose a reason for hiding this comment
The reason will be displayed to describe this comment to others. Learn more.
Hey @mikepsinn - I've reviewed your changes and they look great!
Here's what I looked at during the review
- 🟢 General issues: all looks good
- 🟢 Security: all looks good
- 🟢 Testing: all looks good
- 🟢 Documentation: all looks good
Help me be more useful! Please click 👍 or 👎 on each comment and I'll use the feedback to improve your reviews.
revise dfda-cost-benefit-analysis
revise dfda-cost-benefit-analysis
Summary by Sourcery
Revise the dFDA cost-benefit analysis to improve clarity and structure by adding a detailed QALY calculation appendix, consolidating benefit scenarios, updating sensitivity tables, enhancing narrative with anchors and citations, and renaming the chart label for consistency.
Enhancements:
Documentation: